- Home
- PCVX vs CHE Comparison
PCVX vs CHE Comparison
Compare PCVX & CHE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PCVX
- CHE
- Stock Information
- Founded
- PCVX 2013
- CHE 1970
- Country
- PCVX United States
- CHE United States
- Employees
- PCVX N/A
- CHE N/A
- Industry
- PCVX Biotechnology: Pharmaceutical Preparations
- CHE Medical/Nursing Services
- Sector
- PCVX Health Care
- CHE Health Care
- Exchange
- PCVX Nasdaq
- CHE Nasdaq
- Market Cap
- PCVX 4.4B
- CHE 8.0B
- IPO Year
- PCVX 2020
- CHE N/A
- Fundamental
- Price
- PCVX $33.10
- CHE $485.61
- Analyst Decision
- PCVX Strong Buy
- CHE Strong Buy
- Analyst Count
- PCVX 10
- CHE 2
- Target Price
- PCVX $136.50
- CHE $645.00
- AVG Volume (30 Days)
- PCVX 1.5M
- CHE 174.9K
- Earning Date
- PCVX 08-05-2025
- CHE 07-29-2025
- Dividend Yield
- PCVX N/A
- CHE 0.41%
- EPS Growth
- PCVX N/A
- CHE 10.48
- EPS
- PCVX N/A
- CHE 20.53
- Revenue
- PCVX N/A
- CHE $2,488,997,000.00
- Revenue This Year
- PCVX N/A
- CHE $9.53
- Revenue Next Year
- PCVX N/A
- CHE $6.08
- P/E Ratio
- PCVX N/A
- CHE $23.68
- Revenue Growth
- PCVX N/A
- CHE 8.52
- 52 Week Low
- PCVX $27.66
- CHE $473.55
- 52 Week High
- PCVX $121.06
- CHE $623.61
- Technical
- Relative Strength Index (RSI)
- PCVX 42.61
- CHE 23.33
- Support Level
- PCVX $32.06
- CHE $473.55
- Resistance Level
- PCVX $33.81
- CHE $562.77
- Average True Range (ATR)
- PCVX 1.23
- CHE 9.89
- MACD
- PCVX -0.16
- CHE -5.69
- Stochastic Oscillator
- PCVX 8.44
- CHE 15.00
About PCVX Vaxcyte Inc.
Vaxcyte Inc is a clinical-stage vaccine innovation company engineering high-fidelity vaccines to protect humankind from the consequences of bacterial diseases. It is developing broad-spectrum conjugate and novel protein vaccines to prevent or treat bacterial infectious diseases. Its product comprises of Pneumococcal conjugate vaccine. The firm's product candidate consists of VAX-31, VAX-24, VAX-A1, VAX-PG, VAX-GI, and Others.
About CHE Chemed Corp
Chemed Corp purchases, operates, and divests subsidiaries engaged in diverse business activities to maximize shareholder value. Through its subsidiaries, the company operates in the following segments: VITAS and Roto-Rooter. The VITAS segment generates the majority of the firm's revenue and provides hospice and palliative care services to patients with terminal illnesses through a network of physicians, registered nurses, home health aides, social workers, and volunteers. The Roto-Rooter segment provides plumbing, drain cleaning, water restoration, and related services to residential and commercial customers.